SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boehringer Ingelheim Pharmaceuticals, Inc. Announces Launch of GLORIA(TM)-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation